ESPR

ESPR

USD

Esperion Therapeutics Inc. Common Stock

$2.850+0.000 (0.000%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.850

Kõrge

$2.970

Madal

$2.800

Maht

5.35M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

660.1M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

6.69M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $0.69Praegune $2.850Kõrge $3.94

Seotud uudised

GlobeNewswire

Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

– Brings Extensive Executive Leadership Driving Commercial Strategies That Enhance Sales and Marketing Performance – ANN ARBOR, Mich., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the

Vaata rohkem
Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
GlobeNewswire

Esperion to Participate in Jefferies Global Healthcare Conference - London

ANN ARBOR, Mich., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that the company will present at the Jefferies Global Healthcare Conference – London on November 18, 2025, at 8:00 a.m. GMT

Vaata rohkem
GlobeNewswire

Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in

Vaata rohkem
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025